Mastering Ascites Management in Cirrhosis: PLAB 2 Guidelines
Ascites is one of the most common and challenging presentations you will encounter in your PLAB 2 OSCE stations. This comprehensive guide will equip you with the essential knowledge and practical skills needed to manage patients with cirrhotic ascites according to current UK guidelines.
Understanding Ascites in Cirrhosis
Ascites represents a major complication of decompensated liver cirrhosis, occurring in approximately 60% of patients within 10 years of diagnosis. In the PLAB 2 context, you must demonstrate both theoretical knowledge and practical clinical skills.
Key Pathophysiology Points
Portal hypertension (sinusoidal pressure >12 mmHg)
Hypoalbuminemia reduces oncotic pressure
Renal sodium retention via RAAS activation
Reduced effective circulating volume
Initial Assessment and Diagnosis
History Taking - Essential Points
Onset and progression of abdominal distension
Associated symptoms: Early satiety, breathlessness, ankle swelling
Systemic symptoms: Fever, abdominal pain (suggesting SBP)
Risk factors: Alcohol history, viral hepatitis, NAFLD
Previous episodes of ascites or variceal bleeding
Physical Examination Findings
Abdominal distension with flanks that shift when turning
Fluid thrill (when present)
Striae and prominent superficial veins
Signs of chronic liver disease: Spider nevi, palmar erythema, gynaecomastia
Evidence of portal hypertension: Splenomegaly, hemorrhoids
Diagnostic Investigations
Essential Blood Tests:
LFTs: AST/ALT ratio >1, low albumin, elevated bilirubin
FBC: Anemia, thrombocytopenia
U&E and electrolytes: Hyponatremia, AKI markers
Coagulation: Prolonged PT/INR
Imaging Requirements:
Abdominal ultrasound: Confirm ascites, assess liver texture, portal flow
Doppler studies: Portal vein patency, direction of flow
Paracentesis - The Gold Standard
In PLAB 2, you MUST demonstrate knowledge of diagnostic paracentesis:
Indications:
New onset ascites
Worsening ascites in known cirrhosis
Suspected SBP
Any deterioration in liver failure
Technique (OSCE Pointers):
Position patient supine with slight elevation
Ultrasound guidance preferred (demonstrate this knowledge)
Lateral abdomen, below umbilicus, avoiding surgical scars
Full aseptic technique
Collect 20-30ml for analysis
Essential Fluid Analysis:
Cell count and differential (PMNs >250/μL = SBP)
Protein and albumin (SAAG calculation)
Culture (bedside inoculation preferred)
Cytology if malignancy suspected
Management Algorithm - PLAB 2 Essential
First-Line Management
Grade 1 Ascites (Mild):
Sodium restriction: <2g/day (88 mmol/day)
Fluid restriction: Only if serum Na <125 mmol/L
Monitor weight: Aim for <0.5kg/week loss
Grade 2-3 Ascites (Moderate to Severe):
Diuretic Regimen:
Spironolactone: 100mg daily (initiate)
Furosemide: 40mg daily (add after 3-5 days if needed)
Ratio: 100:40 (maintain)
Maximum doses: Spironolactone 400mg, Furosemide 160mg
Monitoring Schedule:
Weight loss: 0.5-1kg/day initially, then 0.5kg/week
Electrolytes: Twice weekly during titration
Renal function: Monitor creatinine and urea
Second-Line Management
Large Volume Paracentesis (LVP):
Indications: Refractory ascites, respiratory compromise
Technique: Remove all ascitic fluid safely
Essential: Albumin replacement (8g per liter removed)
Post-paracentesis care: Monitor for hypotension, AKI
Refractory Ascites Definition:
Diuretic-resistant: No response to max tolerated doses
Diuretic-intolerant: Unable to continue due to complications
Third-Line Options
TIPS (Transjugular Intrahepatic Portosystemic Shunt):
Reserved for selected patients
Consider hepatic encephalopathy risk
Requires careful patient selection
Long-term Albumin Infusions:
Emerging evidence for regular albumin in refractory ascites
Consider in specific patient groups
Complications and Their Management
Spontaneous Bacterial Peritonitis (SBP)
Clinical Presentation:
Fever, abdominal pain, encephalopathy
May be asymptomatic in 10-30%
High mortality if untreated
Diagnosis:
PMN count >250 cells/μL in ascitic fluid
Culture-positive in 50% of cases
Treatment:
Third-generation cephalosporin: Ceftriaxone 2g daily
Duration: 5 days minimum
Albumin: 1.5g/kg on day 1, 1g/kg on day 3
Prophylaxis: Consider long-term in selected patients
Hepatorenal Syndrome (HRS)
Diagnostic Criteria:
Cirrhosis with ascites
Creatinine >133 μmol/L
No response to volume expansion
Absence of shock, nephrotoxins, structural kidney disease
Treatment:
Terlipressin: 1-2mg IV 6-hourly
Albumin: 1g/kg on day 1, then 20-40g daily
Duration: 7-14 days
Early nephrology consultation essential
Pharmacological Considerations
Diuretic Therapy - Key Points
Spironolactone:
Aldosterone antagonist
Risk of hyperkalemia
Gynecomastia and painful breasts
Start low, go slow
Furosemide:
Loop diuretic
Hypokalemia risk
Less effective in cirrhosis
Use in combination only
Drug Interactions in Liver Disease
Avoid:
NSAIDs: Increase AKI risk
Aminoglycosides: Nephrotoxic
ACE inhibitors/ARBs: Hypotension and AKI risk
Caution:
Benzodiazepines: Encephalopathy risk
Opioids: Accumulation and encephalopathy
Communication Skills - PLAB 2 Scenarios
Breaking Bad News Scenario
Situation: 45-year-old with newly diagnosed cirrhosis and ascites
Structure:
SETUP: Private space, invite family if appropriate
PERCEPTION: "What have you been told so far?"
INVITATION: "Would you like me to explain your diagnosis?"
KNOWLEDGE: Simple language, check understanding
EMOTIONS: Address fears and concerns
STRATEGY: Treatment plan and follow-up
Key Phrases:
"I have some concerning results to discuss..."
"Your liver condition has developed a complication called ascites..."
"This means your liver is not working as well as it should..."
"There are effective treatments available..."
Compliance Discussion
Addressing Sodium Restriction:
"Your recovery depends on reducing salt intake..."
"Many patients find this challenging initially..."
"Let's discuss practical ways to do this..."
Prognosis and Follow-up
Prognostic Indicators
Child-Pugh and MELD scores
Development of complications (HRS, SBP, variceal bleeding)
Response to treatment
Follow-up Schedule
Initial stabilization: Weekly review
Stable patients: Monthly review
Diuretic adjustments: 3-5 day intervals
Red Flags for Referral
Rapidly worsening ascites
Signs of infection (fever, abdominal pain)
Renal impairment
Encephalopathy
GI bleeding
High-Yield PLAB 2 Tips
Always calculate SAAG: >1.1 = Portal hypertension
Know albumin replacement: 8g/L for LVP, weight-based for SBP
Recognize refractory ascites: After optimal diuretic therapy
Remember prophylaxis: Norfloxacin for SBP prevention
TIPS considerations: Hepatic encephalopathy risk
Common Pitfalls to Avoid
Inadequate fluid restriction: Don't restrict fluids unless hyponatremic
Overtreating with diuretics: Monitor electrolytes and renal function
Missing SBP: Always consider in any cirrhotic with ascites
Inadequate albumin replacement: Critical after paracentesis
Ignoring nutrition: Malnutrition common in cirrhosis
Exam-Focused Summary
Essential Facts to Remember:
SAAG >1.1 = Portal hypertension-related ascites
PMN >250 = Diagnostic for SBP
Albumin 8g per liter removed in LVP
Spironolactone 100mg : Furosemide 40mg ratio
Maximum diuretic doses: Spironolactone 400mg, Furosemide 160mg
Key Management Principles:
Conservative first: Sodium restriction, diuretics
Evidence-based: Albumin replacement protocols
Safety-focused: Regular monitoring and complication vigilance
Patient-centered: Address compliance and quality of life
Mastering ascites management demonstrates your ability to handle complex medical scenarios with precision and compassion – exactly what the PLAB 2 examiners are looking for. Practice these algorithms until they become second nature, and you'll handle any ascites-related OSCE station with confidence.
Join the Discussion
Share your thoughts and insights with the medical community
Comments
Delete Comment
Are you sure you want to delete this comment? This action cannot be undone.